Related Experiment Video
Updated: Nov 16, 2025
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
222
Pediatric Neoplasms Presenting with Monocytosis
Jacob R Greenmyer1, Mira Kohorst2
1Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Current Hematologic Malignancy Reports
|February 25, 2021
Summary
Juvenile myelomonocytic leukemia (JMML) is a rare pediatric cancer. Understanding JMML genetics and pathobiology is key to developing targeted therapies beyond stem cell transplant.
Area of Science:
- Pediatric Oncology
- Hematology
- Cancer Genetics
Background:
- Juvenile myelomonocytic leukemia (JMML) is a rare and severe pediatric neoplasm.
- Hematopoietic stem cell transplant is the only established curative option for JMML.
- Understanding JMML pathobiology is crucial for developing targeted therapies.
Purpose of the Study:
- Review JMML with an emphasis on genetics.
- Demonstrate the relationship between JMML genotype and clinical phenotype.
- Explore potential genetic targets for novel JMML therapies.
Main Methods:
- Literature review focusing on JMML genetics and pathobiology.
- Analysis of DNA hypermethylation studies in JMML.
- Investigation of signaling pathways as therapeutic targets.
Main Results:
- DNA hypermethylation correlates with JMML disease severity.
- The PI3K/AKT/MTOR, JAK/STAT, and RAF/MEK/ERK pathways are potential therapeutic targets.
- Targeted therapies show promise for improving JMML patient outcomes.
Conclusions:
- Advances in understanding JMML pathobiology are driving the development of novel therapies.
- Targeted therapeutic approaches hold significant potential for improving outcomes in JMML patients.
Related Concept Videos
01:27Disorders of Leukocytes
1.5K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.5K
01:15Differentiation of Common Myeloid Progenitor Cells
3.6K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.6K
02:23Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K